Medicine and Dentistry
Adverse Event
24%
Analysis
8%
Anticarcinogen
20%
Anticonvulsant
8%
Autonomic Nervous System
11%
Autonomic Neuropathy
8%
Blood Brain Barrier
11%
Bortezomib
55%
Brain
27%
Cancer Therapy
9%
Cells
8%
Cerebrospinal Fluid
9%
Chemotherapeutic Agent
25%
Chemotherapy
23%
Chemotherapy-Induced Peripheral Neuropathy
21%
Cisplatin
11%
Combination Therapy
14%
Development
15%
Dorsal Root
12%
Drug
13%
Epileptic Seizure
26%
Ganglion
11%
Glioblastoma
32%
Gray Matter
10%
Hazard Ratio
8%
Incidence
9%
Inpatient
12%
Interleukin-6
9%
Malignant Neoplasm
17%
Meningeal Carcinomatosis
8%
Multiple Myeloma
24%
Nanoparticle
11%
Nerve Growth Factor
8%
Neuron
18%
Neuropathy
45%
Neurotoxicity
35%
Oxaliplatin
43%
Patient
100%
Peripheral Neuropathy
33%
Pharmacogenetics
8%
Proteasome Inhibitor
22%
Quantitative Sensory Testing
11%
Radiation Therapy
9%
Retreatment
9%
Small Cell Lung Cancer
7%
Surgery
8%
Survival
15%
Therapeutic Procedure
73%
Toxicity
10%
Transitional Cell Carcinoma
8%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
24%
Animal
6%
Anticarcinogen
24%
Anticonvulsive Agent
8%
Autonomic Neuropathy
8%
Blood-Brain Barrier
11%
Bortezomib
65%
Brain Tumor
9%
Carcinomatous Meningitis
8%
Catechol
13%
Chemotherapy
25%
Chemotherapy-Induced Peripheral Neuropathy
21%
Cisplatin
24%
Clinical Feature
6%
Clinical Trial
5%
Colorectal Cancer
13%
Complication
7%
Drug
16%
Epilepsy
5%
Glioblastoma
46%
Gossypol
6%
Immune Checkpoint Inhibitor
7%
Immunoglobulin Enhancer Binding Protein
12%
Incidence
10%
Malignant Neoplasm
22%
Mouse
7%
Mouse Model
7%
Multiple Myeloma
26%
Nanoparticle
18%
Neoplasm
9%
Nerve Growth Factor
8%
Neuropathic Pain
9%
Neuropathy
59%
Neurotoxicity
33%
Normal Human
5%
Oxaliplatin
34%
Oxaliplatin-Induced Neuropathy
5%
Pain
7%
Pathophysiology
6%
Peripheral Neuropathy
40%
Platinum
8%
Proteasome Inhibitor
24%
Protein
5%
Seizure
11%
Side Effect
17%
Survival
17%
Symptom
7%
Taxane
12%
Toxicity
10%
Neuroscience
Adverse Effect
5%
Anticonvulsant
8%
Antineoplastic Drugs
5%
Apoptosis
10%
Astrocytoma
6%
Autonomic Neuropathy
8%
Behavior (Neuroscience)
7%
Bortezomib
77%
Brain
7%
CAG Repeat
6%
Caspase
11%
Cell Survival
5%
Chemotherapy
65%
Cisplatin
16%
DNA
5%
DNA Damage
6%
DNA Degradation
7%
Dorsal Root Ganglion
13%
Endonuclease
11%
Epilepsy
5%
Glioblastoma Multiforme
8%
Gossypol
6%
Immunoglobulin Enhancer Binding Protein
12%
In Vivo
5%
Magnetic Resonance Imaging
5%
Meningeal Carcinomatosis
8%
Nerve Growth Factor
8%
Neuropathic Pain
9%
Neurotoxicity
54%
Oxaliplatin
51%
Peripheral Nerve
6%
Peripheral Neuropathy
74%
Peripheral Neuropathy
62%
Proteasome Inhibitor
25%
Protein
5%
RNA Sequence
5%
Schwann Cell
5%
Seizure
26%
Senescence
5%
Sensory Neuron
13%
Taxane
13%
Transthyretin
5%